We are honored that research from Bentley University https://t.co/kiT3K7Ds8l contributed to this legislation proposed by @RepPeterDeFazio aimed at lowering #drugprices #BentleyUResearch @sciindustry
@ramadeachaval Link al trabajo: https://t.co/xpukTKAGry
@fche @OneFineJay The NIH, plus there are MAJOR tax breaks for R&D, not just in health care, but practically every other industry. Look, I can see why you want to give these people piles of money, I just think you should do it via GoFundMe, like diab
@fche @OneFineJay What is it that you think the NIH does? https://t.co/oddwdQcq6G
@TGBED8v8 In fact, we have directly or indirectly funded every damn pharmaceutical approved by the FDA since at least 2010. https://t.co/oddwdQcq6G
@frozenwarning @LynetteKnott @Smyth_Chris I have sources: https://t.co/ixfi34JPhx You are arguing from authority. I would expect more from an academic. Pharma companies bear no risk from R&D, but reap all the reward.
@ABPI_UK I have sources: https://t.co/ixfi34JPhx
@RTKDEA @EuanCameron4242 @SenSanders Many of our innovations come from public ally funded money(not all of them of course). The last 210 drug innovations received substantial funds from the NIH. https://t.co/3l6TEvQY7Z
@cj_mcree IF Ben had focused on medical innovation, and not cherry picked data about life expectancy, I wouldn't have tweeted. Still, public funding and our public higher ed is vital to our medical innovation, which undercuts the argument for private beu
Insulin: a case study for why we need a public option in the pharmaceutical industry. Article @STATNEWS quotes #BentleyUResearch https://t.co/kiT3K7V2ZT on role of public funding in drug discovery and development https://t.co/FPlJN8xLTN
"Drug companies drive innovation." Ehh. Recent study shows that pretty much every new drug developed recently was initially developed by the government & its funds. Pharma relies on, and monetizes actual government innovation. https://t.co/ucmwxBgUtY
Contribution of NIH funding to new drug approvals 2010–2016 https://t.co/FQI0QfX68w 講義準備していたらこんな論文見つけました。 ・新薬開発に先立ちNIHグラントによるアカデミア基礎研究が必須 ・病理と薬理の研究が超重要 とのこと
Many congratulations to Health TLN member Dr. Cleary for her award!
RT @SciIndustry: Congratulations to Dr. Ekaterina Cleary for receiving the 2019 Outstanding Scholarly Contribution Award @BentleyU for her…
Congratulations to Dr. Ekaterina Cleary for receiving the 2019 Outstanding Scholarly Contribution Award @BentleyU for her publication "Contribution of NIH funding to new drug approvals 2010–2016" @PNAS @BentleyUResearch @SciIndustry https://t.co/PCjIujXMj0
RT @SciIndustry: Congratulations to Dr. Ekaterina Cleary, winner of Bentley University's 2019 Outstanding Scholarly Contribution Award @Ben…
Thrilled and humbled to have received recognition for my research quantifying the contribution of the NIH towards drug development. It was truly a team @SciIndustry effort!
RT @SciIndustry: Congratulations to Dr. Ekaterina Cleary, winner of Bentley University's 2019 Outstanding Scholarly Contribution Award @Ben…
Congratulations to Dr. Ekaterina Cleary, winner of Bentley University's 2019 Outstanding Scholarly Contribution Award @BentleyU for her work @PNAS "Contribution of NIH to new drug approvals 2010-2016" https://t.co/kiT3K7Ds8l
Contribution of NIH funding to new drug approvals 2010–2016 https://t.co/1jmhiTExOa
Timely and important #research from Bentley's @SciIndustry recently informed legislation around #DrugCosts
@secure_bits @mothevarun @RoKhanna Except that every new drug, 210 of them, between 2010 and 2016 were significantly funded by the NIH. Taxpayers prop up the research, then get screwed by Pharma on the backend. https://t.co/zV0KEAduDu
RT @SciIndustry: Senators @ChrisVanHollen @SenRickScott introduce legislation to reduce prescription drug costs based on research from @be…
@FreedomFlyover @kylegriffin1 Not really. You are paying for it: https://t.co/T2E44hOY5Y
.US citizens should get profit sharing on medical research grants that produce medical patents
@GPontificus @PokerPolitics holy shit. you dont know that biotech companies get grants and funding from the govt that allow them to discover new breakthroughs? jesus. https://t.co/RTi7Pwa5uQ
We are honored that our work https://t.co/kiT3K7Ds8l @PNAS contributed to legislation introduced by @ChrisVanHollen and @SenRickScott to recognize @NIH contribution to new drug approvals in drug pricing. @SCIINDUSTRY
Senators @ChrisVanHollen @SenRickScott introduce legislation to reduce prescription drug costs based on research from @bentleyU @sciindustry https://t.co/3gSsEkFxeG https://t.co/fvnFgmccUS
RT @SciIndustry: The new bipartisan Senate bill aimed at making Big Pharma lower drug prices is based on research from @BentleyU @sciindust…
The new bipartisan Senate bill aimed at making Big Pharma lower drug prices is based on research from @BentleyU @sciindustry https://t.co/kiT3K7Ds8l @MSN https://t.co/QMr7pNgP9I
@JoseSampiro @Gonzalo8a05 @jorgenomefui @tevitrek @mauriciomacri Te doy un ejemplo, amigo. El 100% de las nuevas drogas aprobadas por la FDA entre el 2000 y el 2016 en EEUU, surgieron de estudios de ciencia básica financiados por el NIH (un instituto púb
RT @ShmaitlinShmobe: @MarthaPeterson @elle_desylva They tell you that but it's greatly exaggerated. For example, Intel spends a higher per…
@MarthaPeterson @elle_desylva They tell you that but it's greatly exaggerated. For example, Intel spends a higher percentage of their revenue on R&D than pharmaceutical companies. Research is also also heavily subsidized by the NIH & other public
@swannstate @BernieSanders Okay, but there are some big words in there, Gary. Don't hurt yourself. https://t.co/LchTnLNnHC
@DaveSkeptical @muadglib @PhRMA "NIH funding was associated directly or indirectly with every drug approved from 2010–2016 and suggests that the scale of this contribution is larger than generally appreciated." https://t.co/a3QDlSrJ81
@RobertM33296751 @Devilsrain729 @CannibalBananas @rkylesmith @AOC The return on investment for publicly funded pharmaceutical research is through the roof - but please - proceed with your condescension. https://t.co/i6NGRsWgqj
@ConsensusExiled READ the underlying study: >90% of this funding represents basic research related to the biological targets for drug action rather than the drugs themselves. The role of NIH funding thus complements industry research and development,
RT @Haz_el_eyes: @HonestAbe4you @BernieSanders Why would that happen? Since we already pay for a lot of the r&d through NIH research. https…
@HonestAbe4you @BernieSanders Why would that happen? Since we already pay for a lot of the r&d through NIH research. https://t.co/rmShh1Jcf0
@AxelBodine @8Penny8 @ClarkLColeman @kathyb5783 @JStein_WaPo It’s a circular problem - patents allow Pharma to charge excessive prices, so taxpayers ARE functionally funding the research. But according to this research, public funding IS already largely re
RT @sjturn: @buffalo_berger @AAMRI_Aus @JoshFrydenberg @GregHuntMP @nhmrc A mature research strategy able to sustain fundamental research i…
RT @UMRogelCancer: @NIH @umisr @UMich 📢Did you know, @NIH funding contributed to ALL of the 210 new drugs approved by the FDA from 2010-201…
@anthony77980134 @NotCharlotte2 @mpj214 @thehill Well you completely ignored the cancer stats, but whatever. The point of the link was to show the development of the actual drugs was mostly NIH lead(Not only funded). The testing of those drugs and their de
RT @UMRogelCancer: @NIH @umisr @UMich 📢Did you know, @NIH funding contributed to ALL of the 210 new drugs approved by the FDA from 2010-201…
RT @UMRogelCancer: @NIH @umisr @UMich 📢Did you know, @NIH funding contributed to ALL of the 210 new drugs approved by the FDA from 2010-201…
@YoMamaBBG @SenSanders @RepRoKhanna " NIH funding was associated directly or indirectly with every drug approved from 2010–2016 and suggests that the scale of this contribution is larger than generally appreciated" https://t.co/8JzNpPWuF7
RT @knoblog: @beeeesaku @divetoinfinity アカデミアじゃないですが、NIHのファンディングの寄与をPNASがまとめてる論文はありますかね。ご存知かもしれませんが。 https://t.co/cumrAemOPZ
RT @knoblog: @beeeesaku @divetoinfinity アカデミアじゃないですが、NIHのファンディングの寄与をPNASがまとめてる論文はありますかね。ご存知かもしれませんが。 https://t.co/cumrAemOPZ
@beeeesaku @divetoinfinity アカデミアじゃないですが、NIHのファンディングの寄与をPNASがまとめてる論文はありますかね。ご存知かもしれませんが。 https://t.co/cumrAemOPZ
@buffalo_berger @AAMRI_Aus @JoshFrydenberg @GregHuntMP @nhmrc A mature research strategy able to sustain fundamental research is key. As you say, basic research is an investment in new tech, drug development, new therapies https://t.co/8x1zaT57xL https://
It is unrealistic to depend on the private sector to fund basic research of the kind that leads to new classes of drugs & new types of cures. The profit motive has its role, but cannot be expected to serve as the exclusive source of funding for resear
@MWZH1 Another example here ... https://t.co/J1GkfQwZfn
RT @metinhaneke: tüseb’in hem başkanı hem de genel sekreterini “ilaç geliştirme” ile ilgili kişileri atadılar. en başta; ➡️ fonlanma sist…
@AndrewYang You forgot to include the MATH, here's one: Over $100 billion NIH funding -> 210 drugs approved 2010 - 2016. 84 were first-in-class drugs, meaning they treat disease through novel mechanisms or molecular targets https://t.co/PU7zOfRs8t
Great commentary @jflier on complementary roles of academia/industry in drug discovery, development. Policy makers underestimate both public sector cost of basic research https://t.co/kiT3K7Ds8l and private sector cost of applied+translational work to brin
If you want more evidence @Dereklowe, #NIH funding contributed to research on every new drug 2010-6 (total>$100B, as much as $800M for each first-in-class product), this funding focused on drug targets, not the drug itself. https://t.co/kiT3K7Ds8l htt
@ASlavitt @matthewherper @C_Garthwaite Following your tweets several weeks ago: here is the focus of >$100 billion #NIH funding related to drugs approved 2010-2016. Public sector funding for #basicresearch complements industry funding for development.
@ASlavitt @C_Garthwaite @matthewherper We are happy to share our data with anyone @sciindustry @bentleyU https://t.co/kiT3K7Ds8l
@Independent Worse. US taxes fund drug development. “This report shows that NIH funding contributed to published research associated with every one of the 210 new drugs approved by the Food and Drug Administration from 2010–2016.... totaling more than $100
RT @nwnc5th: @SmallGov4All @FreedomWorks @WashTimes @realDonaldTrump @GOP @AFPhq @BayerPharma Of the 210 new drugs approved by the FDA betw…
@SmallGov4All @FreedomWorks @WashTimes @realDonaldTrump @GOP @AFPhq @BayerPharma Of the 210 new drugs approved by the FDA between 2010-2016, every one (ie 100%) benefitted from NIH funding - our tax dollars. Excessive private profits earned from taxpayer i
@anthonygonzalez If you're concerned this would cause a decline in pharmaceutical R&D, don't be. US taxpayers foot the bill for that, not the generous revenues of Big Pharm. "NIH funding contributed to... every one of the 210 new drugs approved by th
@C_Garthwaite I don’t think it’s a tropes ran untruth. 👇 I don’t think it’s the whole story by any means. But taxpayers shouldn’t fund monopolies. https://t.co/0WHMAiBCF0
RT @matthewherper: @ASlavitt This? https://t.co/BT8DfF7O52 It says $100 billion of NIH research went into 210 drugs developed from 2010 to…
@ASlavitt This? https://t.co/BT8DfF7O52 It says $100 billion of NIH research went into 210 drugs developed from 2010 to 2016. But, based on prior research cited: fewer than 10% of drugs are patented in academia; at $1.4 billion per new drug, industry spen
@nburbeck @AndrewYang @MazzucatoM Study that look at NIH funding 2010 - 2016. Over $100B went to research ->210 drugs approved - over $64B contributed to 84 first-in-class drugs, meaning they treat disease through novel mechanisms/ molecular targets. Ne
@Veritas1012 @predictit101 @ddiamond @jaketapper Govt study basic research vs applied: “The role of NIH funding thus complements industry research and development, which focuses predominantly on applied research.” https://t.co/TwMS50bmtJ
. . . "NIH funding contributed to published research associated with every one of the 210 new drugs approved by the Food and Drug Administration from 2010–2016. Collectively, this research involved . . .grant funding totaling more than $100 billion."... h
@ImmunologyAAI NIH $$ matter! Every single one of the 210 FDA approved drugs from 2010-2016 is linked back to NIH funding and basic research!!! https://t.co/WaPtQyexGI
@johnpwilkin @BigMikeHeCooks @AndrewYang Here's also a study that look at public investment on drug r&d. More than $100 billion in NIH funding went toward research that contributed, either directly or indirectly, to the 210 drugs approved between 2010
RT @SciIndustry: Honored that our work @bentleyU @sciindustry @pnas was addressed by @ssworks Nancy Altman today @forbes. While @NIH provid…
@SimoneBoyce @AndrewYang Yes to long-form interview. As a serial entrepreneur, will he also embrace the entrepreneurial state framework advocated by @MazzucatoM et al ? We've been getting atrocious return on our public investment. exhibit 1: https://t.co/P
@businessinsider @AndrewYang Here's a question: Will Yang embrace the entrepreneurial state framework as advocated by @MazzucatoM et al to maximize return on US public investment? Here's an example of missed revenue opportunities for US taxpayers https://t
@AndrewYang Need to get smarter on our public investments and legally require maximum rewards for those investments. After all, management (govt) job is all about maximizing shareholders (americans) value Here's a snapshot (2010-2016) of NIH contribution
@yanghane2020 @YawnMoran @Cyber_Spock @1davidj_ @AndrewYang This narrative (tufts' study) that drug companies spend up to $2.6billion to develop a new drug was based on questionable methodology. We, the taxpayers, need better return for our investment in d
RT @SciIndustry: @FASEBorg Federal funding for basic #biomedical #science creates the essential foundation for the discovery and developmen…
@downtownrob88 @BillyArmagh https://t.co/qJxo2s8PmV https://t.co/vYZqIA1ivC (yes, those are US-focused. So is the drug industry). NRC Canada spent $200M of its $1B on health-stuff: https://t.co/oNxS5d0bhG CIHR spent $1B on "health stuff": https://t.co/NbM3
@FASEBorg Federal funding for basic #biomedical #science creates the essential foundation for the discovery and development of innovative medicines. @NIH @SciIndustry @BentleyU @FASEBorg #FundScience https://t.co/0NGoFykDXY
@AllergyKidsDoc Understandable. I wish that NIH would fund studies looking into some of these more alternative treatments. They seem to invest quite a bit to help fund every other drug study. https://t.co/u0jXIBGJDj
RT @SciIndustry: Watch research from Bentley University @BentleyU https://t.co/kiT3K7Ds8l @sciindustry discussed by Representatives Alexand…
Healthy Funding: The Critical Role of Investing in NIH to Boost Health and Lower Costs @ITIFdc Evidence for impact of NIH funding @BentleyU @sciindustry https://t.co/kiT3K7Ds8l https://t.co/ty9DRFyD83
RT @aronro: @dchernyak @KurtRexCooper @McFaul Basic (aka fundamental) research - without practical application - isn't something that priva…
Watch research from Bentley University @BentleyU https://t.co/kiT3K7Ds8l @sciindustry discussed by Representatives Alexandria Ocasio-Cortez @RepAOC and Ro Kahanna @RoKhanna at House hearing on drug pricing https://t.co/cEOcbR54cF
@bentleyU - Research from Bentley University @sciindustry https://t.co/kiT3K7Ds8l quoted by @jtcone1977 @MSF_USA in @thehill "companies receive substantial publicly-funded support...through public university research, grants, subsidies...incentives" https
@BentleyU - Research from Bentley University quoted in @newrepublic "Building a NASA for Prescription Drugs - a bold solution to America's soaring drug prices" https://t.co/cR9MHAPK0E https://t.co/kiT3K7Ds8l
@BentleyU research cited in report from the Roosevelt Institute on restoring the balance between profits and patients. "This profit-seeking is built in part by the rules that govern the industry..." @rooseveltinst https://t.co/1fO947Nqyp https://t.co/0NGoF
@bentleyu @sciindustry research quoted @RANDCorporation "REDIRECTING INNOVATION IN U.S. HEALTH CARE Options to Decrease Spending and Increase Value" https://t.co/kiT3K7Ds8l https://t.co/Y1K4CiKccS
RT @aronro: @Boris_Badenoff @airplane42 @molratty A large fraction of the fundamental research (with an emphasis on that 'f-word') in the l…
RT @aronro: @dchernyak @KurtRexCooper @McFaul Basic (aka fundamental) research - without practical application - isn't something that priva…
@dchernyak @KurtRexCooper @McFaul Basic (aka fundamental) research - without practical application - isn't something that private industry often funds, no matter how vast their funding. An example of how Federal grants, supporting such research in biomedi